The role of T790M mutations in resistance to first generation EGFR TKIs and what role agents such as Rociletinib may have in the future.

The role of T790M mutations in resistance to first generation EGFR TKIs and what role agents such as Rociletinib may have in the future.

User Photo
lung

5 years
496 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
DAVID ROSS CAMIDGE, MD, PHD, of University of Colorado Denver discusses the role of T790M mutations in resistance to first generation EGFR TKIs and what role agents such as Rociletinib may have in the future.
Up Next Autoplay
>